Notably, various sources, including a recent systematic review, report association of RB1 mutation with poor prognosis including high risk of metastasis11, paralleling observations in other cancers with RB1 involvement12,13 and indicating a clear unmet clinical need in patients with RB1-mutant osteosarcoma. The gene discussed is RB1; the disease is cancer.